CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
CRISPR/Cas9 介导的 PD-1 破坏增强了人嵌合抗原受体 T 细胞的抗肿瘤功效
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-017-00462-8
Levi J Rupp, Kathrin Schumann, Kole T Roybal, Rachel E Gate, Chun J Ye, Wendell A Lim, Alexander Marson4
